SK bioscience

본문바로가기

사이트맵 닫기

PR

SK bioscience company news updates

Press Releases

SK Bioscience - Novavax-KDCA Sign Licensing Agreement and Purchase Agreement for Novavax´ COVID-19 Vaccine Candidate

2021 .02 .16
SK bioscience Submits Securities Report Aiming for KOSPI Listing by March

2021. 02. 08
SK bioscience Collaborates with GSK on COVID-19 Vaccine Development

2021. 02. 05
SK bioscience Signs Joint Sales Contract of Five Major Vaccines with GSK

2021. 01. 06
SK bioscience’s Typhoid Conjugate Vaccine Candidate Demonstrates Successful Phase III Clinical Trial Results

2020. 12. 17
SK bioscience’s COVID-19 Vaccine Candidate Is Chosen to First ‘Wave2’ Supporting Candidate

2020. 12. 10
SK bioscience-Seoul National University Hospital Agree Clinical Trial Cooperation for COVID-19 Vaccine ‘NBP2001’

2020. 12. 02
SK bioscience Announces Filing for KOSPI IPO

2020. 11. 30
SK bioscience’s COVID-19 Vaccine Candidate Enters Clinical Trial

2020. 11. 25
SK bioscience-Novavax Sign CDMO of COVID-19 Vaccine Agreement with Novavax

2020. 08. 14
SK biosciences Underwriters for IPO Promotion

2020. 07. 26
SK bioscience - Ministry of Health and Welfare - AstraZeneca Agree Trilateral Partnership for Cooperation for Global Supply of the COVID-19 Vaccine

2020. 07. 21